← FDA DRUG APPROVALS

FDA ANDA · ANDA040360

PERPHENAZINE

Sponsor: PHARM ASSOC

APPLICATION
ANDA040360
TYPE
ANDA
ORIGINAL APPROVAL
2001-05-25
LATEST ACTION
2001-05-25
ROUTE
ORAL
DOSAGE FORM
CONCENTRATE
MARKETING STATUS
Discontinued

Products

PERPHENAZINEDiscontinued
PERPHENAZINE 16MG/5ML · CONCENTRATE · ORAL

Approval history

2001-05-25OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →